All In MedTech

FDA Clearance Tracker · P060002-S027

FLAIR ENDOVASCULAR STENT GRAFT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 16, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 16, 2013

Approved

Time to decision

181 days

Received Jul 19, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P060002-S027
Device name
FLAIR ENDOVASCULAR STENT GRAFT
Applicant location
Tempe, AZ
Received
Jul 19, 2012
Decided
Jan 16, 2013
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P060002

Device type

Device class
Class III

Every decision under product code PFV

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A LINE EXTENSION OF THE FLAIR® ENDOVASCULAR STENT GRAFT TO ADD A 70 MM LENGTH. IN ADDITION, THERE ARE THREE ADDITIONAL MINOR CHANGES. THESE INCLUDED: MANUFACTURING CORE MODIFICATION, DELIVERY SYSTEM FLARING MANDREL MODIFICATION, AND CHAMFER OF GUIDING TUBE MODIFICATION.

Source documents

Other decisions for Bard Peripheral Vascular

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.